Jackson Grant Investment Advisers’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.82M Sell
24,067
-35
-0.1% -$5.21K 1.19% 17
2026
Q1
$3.53M Sell
24,102
-108
-0.4% -$16.7K 1.18% 17
2025
Q4
$3.75M Buy
24,210
+280
+1% +$41.9K 1.23% 18
2025
Q3
$3.33M Buy
23,930
+70
+0.3% +$9.47K 1.11% 18
2025
Q2
$3.22M Sell
23,860
-99
-0.4% -$13.4K 1.18% 18
2025
Q1
$3.5M Buy
23,959
+181
+0.8% +$26.3K 1.35% 17
2024
Q4
$3.27M Buy
23,778
+65
+0.3% +$9.51K 1.26% 17
2024
Q3
$3.65M Buy
23,713
+57
+0.2% +$8.64K 1.37% 18
2024
Q2
$3.45M Sell
23,656
-35
-0.1% -$5.02K 1.39% 18
2024
Q1
$3.5M Sell
23,691
-861
-4% -$124K 1.43% 16
2023
Q4
$3.35M Sell
24,552
-275
-1% -$35.8K 1.48% 17
2023
Q3
$3.2M Sell
24,827
-53
-0.2% -$7.04K 1.54% 17
2023
Q2
$3.3M Buy
24,880
+73
+0.3% +$9.62K 1.53% 17
2023
Q1
$3.21M Sell
24,807
-207
-0.8% -$27K 1.51% 15
2022
Q4
$3.4M Buy
25,014
+451
+2% +$59.8K 1.64% 15
2022
Q3
$2.98M Buy
24,563
+64
+0.3% +$8.24K 1.56% 15
2022
Q2
$3.14M Sell
24,499
-48
-0.2% -$6.29K 1.56% 14
2022
Q1
$3.36M Buy
24,547
+156
+0.6% +$20.7K 1.41% 16
2021
Q4
$3.44M Sell
24,391
-48
-0.2% -$6.37K 1.75% 14
2021
Q3
$3.11M Sell
24,439
-922
-4% -$122K 1.39% 16
2021
Q2
$3.19M Sell
25,361
-1,350
-5% -$165K 1.4% 16
2021
Q1
$3.12M Buy
26,711
+72
+0.3% +$8.31K 1.43% 16
2020
Q4
$3.02M Sell
26,639
-1,631
-6% -$178K 1.54% 16
2020
Q3
$2.98M Buy
28,270
+103
+0.4% +$10.8K 1.79% 14
2020
Q2
$2.82M Sell
28,167
-1,148
-4% -$113K 1.79% 15
2020
Q1
$2.6M Buy
29,315
+717
+3% +$69.7K 1.92% 12
2019
Q4
$2.91M Sell
28,598
-2,079
-7% -$200K 1.58% 15
2019
Q3
$2.77M Sell
30,677
-247
-0.8% -$22.6K 1.57% 15
2019
Q2
$2.87M Sell
30,924
-2,835
-8% -$255K 1.67% 14
2019
Q1
$3.1M Sell
33,759
-344
-1% -$31K 1.86% 13
2018
Q4
$2.95M Sell
34,103
-565
-2% -$51.1K 2.07% 11
2018
Q3
$3.3M Buy
34,668
+1,364
+4% +$123K 2.07% 10
2018
Q2
$2.78M Sell
33,304
-1,168
-3% -$96.8K 1.91% 12
2018
Q1
$2.81M Sell
34,472
-104
-0.3% -$8.86K 1.96% 12
2017
Q4
$2.86M Buy
34,576
+1,129
+3% +$93.1K 1.93% 12
2017
Q3
$2.73M Sell
33,447
-804
-2% -$64.6K 1.98% 12
2017
Q2
$2.71M Buy
34,251
+92
+0.3% +$7.01K 2.11% 10
2017
Q1
$2.54M Sell
34,159
-696
-2% -$50.7K 2.04% 11
2016
Q4
$2.4M Sell
34,855
-235
-0.7% -$16.3K 2.04% 11
2016
Q3
$2.53M Sell
35,090
-1,000
-3% -$73.6K 2.09% 10
2016
Q2
$2.59M Sell
36,090
-761
-2% -$53.6K 2.28% 10
2016
Q1
$2.5M Buy
36,851
+4,847
+15% +$325K 2.28% 10
2015
Q4
$2.31M Buy
+32,004
New +$2.26M 2.19% 10

Other funds holding XLV

Jackson Grant Investment Advisers's XLV Position: Q2 2026 in Review

Jackson Grant Investment Advisers reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 0.15% in Q2 2026, selling an estimated $5.21K and leaving 24,067 shares worth $3.82M. The position accounts for 1.19% of the portfolio, ranked #17.

Jackson Grant Investment Advisers first reported a position in XLV in Q4 2015 and has held it in 43 quarters since. 878 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Jackson Grant Investment Advisers held 24,067 shares of State Street Health Care Select Sector SPDR ETF worth $3.82M as of Q2 2026.
  • Jackson Grant Investment Advisers sold 35 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $5.21K.
  • State Street Health Care Select Sector SPDR ETF made up 1.19% of Jackson Grant Investment Advisers's portfolio in Q2 2026, its #17 holding.
  • Jackson Grant Investment Advisers first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2015 and has held it in 43 quarters since.
  • 878 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Jackson Grant Investment Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.